Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
2.400
-0.095 (-3.81%)
At close: Sep 25, 2026, 4:00 PM EDT
2.410
+0.010 (0.42%)
After-hours: Sep 25, 2026, 7:30 PM EDT
Ovid Therapeutics Market Cap
Ovid Therapeutics has a market cap or net worth of $468.71 million as of September 25, 2026. Its market cap has increased by 370.60% in one year.
Market Cap
468.71M
Enterprise Value
311.66M
1-Year Change
370.60%
Ranking
Category
Stock Price
$2.40
ChartMarket Cap Chart
Since May 5, 2017, Ovid Therapeutics's market cap has increased from $301.40M to $468.71M, an increase of 55.51%. That is a compound annual growth rate of 4.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 468.70M | 303.70% |
| Dec 31, 2025 | 116.10M | 75.11% |
| Dec 31, 2024 | 66.30M | -70.87% |
| Dec 29, 2023 | 227.60M | 73.61% |
| Dec 30, 2022 | 131.10M | -40.03% |
| Dec 31, 2021 | 218.60M | 49.22% |
| Dec 31, 2020 | 146.50M | -26.16% |
| Dec 31, 2019 | 198.40M | 232.33% |
| Dec 31, 2018 | 59.70M | -75.41% |
| Dec 29, 2017 | 242.80M | -19.44% |
| May 5, 2017 | 301.40M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AgomAb Therapeutics NV | 521.04M |
| Arvinas | 509.36M |
| Autolus Therapeutics | 508.37M |
| ProKidney | 507.90M |
| Puma Biotechnology | 506.91M |
| Capricor Therapeutics | 498.25M |
| Entera Bio | 484.80M |
| Assembly Biosciences | 481.73M |